ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01111032
Recruitment Status : Completed
First Posted : April 27, 2010
Last Update Posted : October 1, 2013
Sponsor:
Collaborator:
McMaster University
Information provided by (Responsible Party):
Oren Cheifetz, McMaster University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
During this study the investigators will compare the use of two treadmill tests in people diagnosed with cancer. The STEEP treadmill protocol is often used to evaluate the endurance of people diagnosed with cancer, however, since it is based on step increases in speed or ramp, it may not related to normal function. The new test, which is based on the body response to increased activity has not been used with people with cancer but may provide a better approximation of endurance demands during daily function. Our question is whether the new treadmill test can be used to evaluate aerobic function with people with cancer better than the STEEP treadmill test.

Condition or disease
Cancer

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 12 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Two-treadmill Test Protocols to Evaluate Endurance in People With Cancer.
Study Start Date : May 2011
Actual Primary Completion Date : October 2011
Actual Study Completion Date : December 2011
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Treadmill test


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. STEEP treadmill test [ Time Frame: 1 hour ]
    Treadmill test for endurance. Lasts approx 15 min with 45 min recovery


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult well cancer survivors
Criteria

Inclusion Criteria:

  • Participants are required to be adults (age 16 or over),
  • Diagnosed with cancer, at any stage of treatment (during or after treatment),
  • Able to follow instructions in English, and provide informed consent.
  • Participants need to be considered "well" to participate. A "well participant" has been defined as a cancer survivor who is living at home, able to ambulate independently without a gait aid (single point cane is acceptable), has no acute medical conditions, and passes pre-exercise safety screening.

Exclusion Criteria:

  • Cancer survivors with metastatic disease.
  • Cancer survivors who are defined as unwell.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01111032


Locations
Canada, Ontario
Hamilton Health Sciences, Henderson Campus
Hamilton, Ontario, Canada, L8V 1C3
Sponsors and Collaborators
Hamilton Health Sciences Corporation
McMaster University
Investigators
Principal Investigator: Oren Cheifetz, M.Sc. PT Hamilton Health Sciences Corporation
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Oren Cheifetz, Clinical Specialist - Physiotherapy, McMaster University
ClinicalTrials.gov Identifier: NCT01111032     History of Changes
Other Study ID Numbers: Treadmill Comparison
First Posted: April 27, 2010    Key Record Dates
Last Update Posted: October 1, 2013
Last Verified: September 2013

Keywords provided by Oren Cheifetz, McMaster University:
Treadmill
Exercise
Cancer
Validity
Reliability